T
15.04
0.03 (0.20%)
| Previous Close | 15.01 |
| Open | 15.10 |
| Volume | 1,698,591 |
| Avg. Volume (3M) | 1,762,467 |
| Market Cap | 48,002,265,088 |
| Price / Earnings (TTM) | 34.98 |
| Price / Earnings (Forward) | 35.97 |
| Price / Sales | 1.47 |
| Price / Book | 0.890 |
| 52 Weeks Range | |
| Earnings Date | 8 May 2025 |
| TTM Dividend Yield | 1,310.58% |
| Profit Margin | 4.54% |
| Operating Margin (TTM) | 0.53% |
| Diluted EPS (TTM) | 0.450 |
| Quarterly Revenue Growth (YOY) | 3.00% |
| Quarterly Earnings Growth (YOY) | -77.50% |
| Total Debt/Equity (MRQ) | 73.21% |
| Current Ratio (MRQ) | 1.31 |
| Operating Cash Flow (TTM) | 1.11 T |
| Levered Free Cash Flow (TTM) | 756.41 B |
| Return on Assets (TTM) | 2.51% |
| Return on Equity (TTM) | 2.94% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
| Stock | Takeda Pharmaceutical Company L | Mixed | Mixed |
AIStockmoo Score
-2.1
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -3.5 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -2.0 |
| Average | -2.13 |
|
Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Large Core |
| % Held by Insiders | 0.01% |
| % Held by Institutions | 2.32% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Managed Asset Portfolios, Llc | 31 Dec 2024 | 1,417,448 |
| Soleus Capital Management, L.P. | 31 Dec 2024 | 1,180,000 |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 1,310.58% |
| 5Y Average Dividend Yield | 3.39% |
| Payout Ratio | 140.03% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 30 Mar 2023 | 15 Mar 2023 | 10 Jul 2023 | 0.30996 Cash |
| 29 Sep 2022 | 13 Sep 2022 | 12 Dec 2022 | 0.329553 Cash |
| 30 Mar 2022 | 04 Mar 2022 | 11 Jul 2022 | 0.330062 Cash |
| 29 Sep 2021 | - | 13 Dec 2021 | 0.396898 Cash |
| 30 Mar 2021 | 15 Mar 2021 | 12 Jul 2021 | 0.406627 Cash |
| 29 Sep 2020 | - | 11 Dec 2020 | 0.430533 Cash |
| 30 Mar 2020 | - | 06 Jul 2020 | 0.419053 Cash |
| 27 Sep 2019 | 09 Sep 2019 | 12 Dec 2019 | 0.411118 Cash |
| 28 Mar 2019 | 16 Mar 2019 | 10 Jul 2019 | 0.417168 Cash |
| 26 Sep 2018 | - | 13 Dec 2018 | 0.395501 Cash |
| 27 Mar 2018 | - | 09 Jul 2018 | 0.40643 Cash |
| 27 Sep 2017 | - | 11 Dec 2017 | 0.39946 Cash |
| 29 Mar 2017 | - | 10 Jul 2017 | 0.39892 Cash |
| 28 Sep 2016 | - | 12 Dec 2016 | 0.392415 Cash |
| 29 Mar 2016 | - | 11 Jul 2016 | 0.43705 Cash |
| 28 Sep 2015 | - | 11 Dec 2015 | 0.365323 Cash |
| 27 Mar 2015 | - | 09 Jul 2015 | 0.365289 Cash |
| 25 Sep 2014 | - | 11 Dec 2014 | 0.378342 Cash |
| 26 Mar 2014 | - | 10 Jul 2014 | 0.443655 Cash |
| 25 Sep 2013 | - | 12 Dec 2013 | 0.436978 Cash |
| 26 Mar 2013 | - | 08 Jul 2013 | 0.457131 Cash |
| 25 Sep 2012 | - | 13 Dec 2012 | 0.545983 Cash |
| 27 Mar 2012 | - | 09 Jul 2012 | 0.563768 Cash |
| 27 Sep 2011 | - | 12 Dec 2011 | 0.578629 Cash |
| 28 Mar 2011 | - | 07 Jul 2011 | 0.555761 Cash |
| 27 Sep 2010 | - | 13 Dec 2010 | 0.533229 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2023 | 0.310 | 1 | 2.17 |
| 2022 | 0.660 | 2 | 4.23 |
| 2021 | 0.804 | 2 | 5.90 |
| 2020 | 0.850 | 2 | 4.67 |
| 2019 | 0.828 | 2 | 4.20 |
| 2018 | 0.802 | 2 | 4.77 |
| 2017 | 0.798 | 2 | 2.81 |
| 2016 | 0.829 | 2 | 3.99 |
| 2015 | 0.731 | 2 | 2.92 |
| 2014 | 0.822 | 2 | 3.96 |
| 2013 | 0.894 | 2 | 3.88 |
| 2012 | 1.11 | 2 | 5.00 |
| 2011 | 1.13 | 2 | 5.15 |
| 2010 | 0.533 | 1 | 2.19 |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |